Physician profile
Tad Gerlinger
NPI 1922097971
$641,507.38
in general payments reported to CMS, 2019-2025
8 companies · $89K in 2025
The $89K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152K · 2020: $68K · 2021: $34K · 2022: $77K · 2023: $126K · 2024: $97K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $226K · Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Travel and Lodging: $17K · Food and Beverage: $2,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $226,353.02 |
| Consulting Fee | $35,249.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,062.50 |
| Travel and Lodging | $17,486.47 |
| Food and Beverage | $2,018.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $604,419.96 | 2019-2025 | Journey II, Real Intelligence, Tandem |
| Kyocera Medical Technologies, INC. | $27,142.19 | 2022-2025 | |
| Graymont Professional Products Ip, LLC | $5,000.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $2,011.23 | 2024-2025 | |
| Kci USA, INC. | $1,600.00 | 2019 | |
| Medical Device Business Services, INC. | $1,170.00 | 2021 | |
| Engage Uni, LLC | $114.00 | 2021 | |
| Solventum Corporation | $50.00 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tad Gerlinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.